IART (STOCKS)
Integra LifeSciences Holdings
$17.460000
-0.310000 (-1.74%)
Prev close: $17.770000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stuart M. Essig
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,357.56M
- Employees
- 4,396
- P/E (TTM)
- -2.70
- P/B (TTM)
- 1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
1
Buy
8
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.54 | $0.41 | +0.1274 | +30.88% |
|
Dec 2025 (Q4)
|
$0.83 | $0.82 | +0.0137 | +1.68% |
|
Sep 2025 (Q3)
|
$0.54 | $0.44 | +0.0963 | +21.70% |
|
Jun 2025 (Q2)
|
$0.45 | $0.44 | +0.0098 | +2.23% |
Financial Statements
| Revenues | $1.64B |
| Benefits Costs and Expenses | $2.18B |
| Cost Of Revenue | $790.34M |
| Costs And Expenses | $2.11B |
| Gross Profit | $854.17M |
| Operating Expenses | $1.32B |
| Selling, General, and Administrative Expenses | $696.44M |
| Other Operating Expenses | $624.14M |
| Operating Income/Loss | -$466.40M |
| Income/Loss From Continuing Operations After Tax | -$495.80M |
| Income/Loss From Continuing Operations Before Tax | -$535.88M |
| Income Tax Expense/Benefit | -$40.08M |
| Income Tax Expense/Benefit, Deferred | -$63.11M |
| Net Income/Loss | -$495.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$495.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$495.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.46 |
| Diluted Earnings Per Share | -$6.46 |
| Basic Average Shares | 230,434,000 |
| Diluted Average Shares | 230,434,000 |
| Assets | $3.58B |
| Current Assets | $1.17B |
| Inventory | $495.04M |
| Prepaid Expenses | $97.71M |
| Other Current Assets | $579.27M |
| Noncurrent Assets | $2.41B |
| Fixed Assets | $446.88M |
| Intangible Assets | $1.11B |
| Other Non-current Assets | $853.48M |
| Liabilities | $2.54B |
| Current Liabilities | $346.85M |
| Wages | $58.04M |
| Other Current Liabilities | $288.81M |
| Noncurrent Liabilities | $2.19B |
| Long-term Debt | $716.88M |
| Other Non-current Liabilities | $1.47B |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.04B |
| Liabilities And Equity | $3.58B |
| Net Cash Flow From Operating Activities | $71.44M |
| Net Cash Flow From Operating Activities, Continuing | $71.44M |
| Net Cash Flow From Investing Activities | -$86.99M |
| Net Cash Flow From Investing Activities, Continuing | -$86.99M |
| Net Cash Flow From Financing Activities | $1.26M |
| Net Cash Flow From Financing Activities, Continuing | $1.26M |
| Exchange Gains/Losses | $12.00M |
| Net Cash Flow | -$2.30M |
| Net Cash Flow, Continuing | -$14.29M |
| Comprehensive Income/Loss | -$495.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$502.63M |
| Other Comprehensive Income/Loss | -$11.76M |
| Other Comprehensive Income/Loss Attributable To Parent | -$6.83M |